dimarts, 16 de setembre del 2014

TCT 2014: Medtronic's IN.PACT Admiral beats PTA in outcomes, costs




Medtronic unveils 1-year study results showing that its IN.PACT Admiral drug-coated balloon is clinically superior and more cost-effective than standard percutaneous transluminal angioplasty.





TCT 2014: Medtronic's Admiral drug-coated balloon beats PTA in outcomes, cost

Medtronic, TCT 2014

News Well, Clinical Trials, Conference coverage, Minnesota, Peripheral Artery Disease, Transcatheter Cardiovascular Therapeutics symposium (TCT)

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1t7KWzv
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)